By using, you agree to our terms and use of cookies to enhance your experience.

Managing hyperglycaemia in kidney disease guidelines launched

By Editor
15th June 2018
Audits, Care planning Clinical guidance

Guidelines on managing hyperglycaemia in kidney disease have now been finalised by members of a national group which represents diabetes consultants in the UK.

The Association of British Clinical Diabetologists (ABCD) and the Renal Association clinical specialty work programme has released a summary of the full guidelines with audit standards and issues for future research. This guidance appeared in the June issue of the British Journal of Diabetes.

The document features information about glycaemic targets in the prevention and management of diabetic nephropathy and chronic kidney disease, insulin therapy guidance and looking at a series of medications. A series of recommendations have also been provided, along with suggested areas which require further research.

There is also a medicines sick day guidance, which includes advice to people with diabetes about which treatment to avoid taking should they become persistently sicko, sweating or shaking violently.

A welcome addition to  the resources for clinicians to  manage these patients in day to day clinical practice.

To read the guidelines, click here.

Comments (0)

Register an account or login to comment